Insmed

Yahoo Finance • 3 days ago

Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The Fund performed roughly in line with the Benchmark, during a challenging quarter for the larger health care indust... Full story

Yahoo Finance • 15 days ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., Feb. 7, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious di... Full story

Yahoo Finance • 5 months ago

Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024?

We recently published a list of the 7 Best Performing Long Term Stocks in 2024. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other best performing long term stocks in 2024. Aft... Full story

Yahoo Finance • 5 months ago

Is Insmed Inc. (INSM) the Best Performing Stock in 2024?

We recently compiled a list of the 10 Best Performing Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great-performing stocks. Dow Breaks Record The Dow Jones Indust... Full story

Yahoo Finance • 6 months ago

Decoding Insmed Inc (INSM): A Strategic SWOT Insight

Insmed Inc's ARIKAYCE remains a key strength with robust market acceptance. Dependence on third-party manufacturers and suppliers presents a notable weakness. Opportunities for growth lie in potential approvals and commercialization of bre... Full story

Yahoo Finance • 9 months ago

Insmed Announces Proposed $500 Million Public Offering of Common Stock

BRIDGEWATER, N.J., May 28, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it intends to offer... Full story

Yahoo Finance • 9 months ago

Is Insmed Incorporated (NASDAQ:INSM) a Buy According to Hedge Funds?

We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we will dissect whether Insmed Incorporated (NASDAQ:INSM) is a top healthcare pick of elite hedge funds. Challenges in the Health Sector T... Full story

Yahoo Finance • 10 months ago

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update

— ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $75.5 Million for the First Quarter of 2024, Reflecting 16% Annual Growth Over the First Quarter of 2023— —Company Reports Positive Topline Safety and Tolerability Dat... Full story

Yahoo Finance • last year

Insmed To Present at the Nasdaq 49th Investor Conference

BRIDGEWATER, N.J., Nov. 29, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will pr... Full story

Yahoo Finance • 2 years ago

12 Best Biotech Stocks To Buy Under $20

In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy Under $20. The biotechnology industry is one of the hottest sectors right now, particul... Full story

Yahoo Finance • 2 years ago

Insiders of Insmed Incorporated (NASDAQ:INSM) are up 17% on their US$1.7m purchase after Insmed Incorporated (NASDAQ:INSM) rose 5.0% last week

Insmed Incorporated (NASDAQ:INSM) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose 5.0%, resulting in a US$134m rise in the company's market capitalisation. As a result, the stock they origin... Full story

Yahoo Finance • 2 years ago

Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023

BRIDGEWATER, N.J., Feb. 9, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its... Full story

Yahoo Finance • 2 years ago

Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference

—Topline Data from Phase 2 PK/PD Study of Brensocatib in Patients with Cystic Fibrosis Show Clear Dose Response at all Evaluated Doses— —Treatment Discontinuation Rate of 15% Reported in Postmarketing ARISE Trial of ARIKAYCE® (amikacin li... Full story

Yahoo Finance • 2 years ago

Insmed To Present at the Nasdaq 47th Investor Conference

BRIDGEWATER, N.J., Nov. 30, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will pre... Full story

Yahoo Finance • 3 years ago

Goldman Sachs Sees These 2 ‘Strong Buy’ Stocks Skyrocketing Over 70%

Just when it looked like time to throw in the towel, the market pulled through and delivered a win. After April turned out to be the worst month since March 2020, May kicked off in a more upbeat fashion, with investors hoping the bottom mi... Full story